Skip to main content
Christopher Rohde, MD, Family Medicine, Ellsworth AFB, SD

ChristopherScottRohdeMD

Family Medicine Ellsworth AFB, SD

Physician

Are you Dr. Rohde?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 15 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    2900 Doolittle Dr
    Ellsworth AFB, SD 57706
    Phone+1 605-385-3002
    Fax+1 605-385-3126

Summary

  • Dr. Christopher Rohde, MD is a board certified family physician in Ellsworth AFB, South Dakota. He is currently licensed to practice medicine in South Dakota.

Education & Training

  • USAF School of Aerospace Medicine Aerospace Medicine
    USAF School of Aerospace Medicine Aerospace MedicineResidency, Preventive Medicine, 2012 - 2013
  • Rapid City Hospital
    Rapid City HospitalResidency, Family Medicine, 1995 - 1998
  • University of South Dakota, Sanford School of Medicine
    University of South Dakota, Sanford School of MedicineClass of 1995

Certifications & Licensure

  • SD State Medical License
    SD State Medical License Active through 2025
  • American Board of Family Medicine Family Medicine
  • American Board of Preventive Medicine Occupational Medicine

Press Mentions

  • Brooklyn ImmunoTherapeutics to Participate in Grand Opening of Cambridge-Based mRNA Cleanroom Facility Shared with Factor Bioscience
    Brooklyn ImmunoTherapeutics to Participate in Grand Opening of Cambridge-Based mRNA Cleanroom Facility Shared with Factor BioscienceSeptember 9th, 2021
  • Christopher Rohde, Ph.D. To Join Scientific Advisory Board Of
    Christopher Rohde, Ph.D. To Join Scientific Advisory Board OfMay 13th, 2021
  • Treatment of Bipolar Disorder with Valproate and Antipsychotics Linked to Risk of Diabetes Mellitus
    Treatment of Bipolar Disorder with Valproate and Antipsychotics Linked to Risk of Diabetes MellitusJune 27th, 2023